Clinical Trial Update: A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating saxagliptin in adults with type 2 diabetes not controlled by diet and exercise has completed, with results posted in January 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-01-21